Cargando…

Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts

BACKGROUND: Long-term use of anti-resorptive or anti-angiogenic drugs in cancer patients with odontogenic infections may lead to medication-related osteonecrosis of the jaw (MRONJ). This study investigated whether anti-angiogenic agents aggravate MRONJ occurrence in anti-resorptive-treated patients....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Ning, Li, Qing-xiang, Wang, Yi-fei, Qiao, Qiao, Huang, Hong-yuan, Guo, Chuan-bin, Guo, Yu-xing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225109/ https://www.ncbi.nlm.nih.gov/pubmed/37245004 http://dx.doi.org/10.1186/s12903-023-03034-7

Ejemplares similares

Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
por: Petcu, Eugen B, et al.
Publicado: (2012)

Predictive factors for refractory stage I and II anti-resorptive agent-related osteonecrosis of the jaw
por: Shimizu, Takahiro, et al.
Publicado: (2021)

Incidence and Risk of Anti-Resorptive Agent-Related Osteonecrosis of the Jaw after Tooth Extraction: A Retrospective Study
por: Shimizu, Rieko, et al.
Publicado: (2022)

Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect
por: Sharma, Dileep, et al.
Publicado: (2013)

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (6), assessment of mandibular metabolism due to long-term administration of an anti-resorptive agent by bone scintigraphy (secondary publication)()()
por: Ohbayashi, Yumiko, et al.
Publicado: (2019)

Sales for anti-angiogenic drugs
por: Ribatti, Domenico
Publicado: (2017)

Review and update on drugs related to the development of osteonecrosis of the jaw
por: Eguia, Asier, et al.
Publicado: (2020)

Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis
por: Morita, Mayu, et al.
Publicado: (2017)

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (1), role of imaging in drug-related osteonecrosis of the jaw: An up-to-date review (secondary publication)()
por: Tsuchimochi, Makoto, et al.
Publicado: (2019)

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)()
por: Baba, Akira, et al.
Publicado: (2019)

Reactive resistance to anti-angiogenic drugs
por: Bousquet, Guilhem, et al.
Publicado: (2015)

Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw()
por: Kitagawa, Yoshimasa, et al.
Publicado: (2019)

Human gingival fibroblast secretome accelerates wound healing through anti-inflammatory and pro-angiogenic mechanisms
por: Ahangar, Parinaz, et al.
Publicado: (2020)

Osteonecrosis of the Jaw
por: Lončar Brzak, Božana, et al.
Publicado: (2023)

The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs
por: Barillari, Giovanni
Publicado: (2020)

The effect of drug holiday on preventing medication-related osteonecrosis of the jaw in osteoporotic rat model
por: Zhu, Wang-yong, et al.
Publicado: (2023)

Drug holiday as a prognostic factor of medication-related osteonecrosis of the jaw
por: Kim, Yoon Ho, et al.
Publicado: (2014)

Anti-Angiogenic Activity of Drugs in Multiple Myeloma
por: Saltarella, Ilaria, et al.
Publicado: (2023)

Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan
por: Shibahara, Takahiko
Publicado: (2019)

Does Drug Holiday Affect Jaw Trabeculation in Medication Related Osteonecrosis of the Jaw? – A Pilot Study
por: Panneer-Selvam, Niranzena, et al.
Publicado: (2022)

Denosumab and osteonecrosis of the jaw
por: Bower, Robert
Publicado: (2019)

Osteonecrosis of the jaw and denosumab
por: Goss, Alastair N
Publicado: (2022)

Letter to the editor regarding “Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw”
por: Nastro Siniscalchi, E., et al.
Publicado: (2020)

Clinical significance of drug cessation on medication-related osteonecrosis of the jaw in patients with osteoporosis
por: Mustakim, Kezia Rachellea, et al.
Publicado: (2023)

Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers
por: Sulaiman, Raed, et al.
Publicado: (2023)

Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging
por: Okui, Taro, et al.
Publicado: (2020)

Comparison of effects of anti-angiogenic agents in the zebrafish efficacy–toxicity model for translational anti-angiogenic drug discovery
por: Chimote, Geetanjali, et al.
Publicado: (2014)

Effect of gingival fibroblasts and ultrasound on dogs' root resorption during orthodontic treatment
por: Crossman, Jacqueline, et al.
Publicado: (2017)

S100 Calcium Binding Protein A9 Represses Angiogenic Activity and Aggravates Osteonecrosis of the Femoral Head
por: Wu, Re-Wen, et al.
Publicado: (2019)

Anti-angiogenic drugs: direct anti-cancer agents with mitochondrial mechanisms of action
por: Quayle, Lewis A., et al.
Publicado: (2017)

Bisphophonates related osteonecrosis of the jaw
por: Gupta, Swati, et al.
Publicado: (2013)

Correction to: Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging
por: Okui, Taro, et al.
Publicado: (2022)

Current prospective management of patients with osteonecrosis drug-induced (bisphosphonates) of the jaws: our experience
por: Giudice, M, et al.
Publicado: (2010)

Tetrahedral framework nucleic acid carrying angiogenic peptide prevents bisphosphonate-related osteonecrosis of the jaw by promoting angiogenesis
por: Zhao, Dan, et al.
Publicado: (2022)

Anti-angiogenic drug scheduling optimisation with application to colorectal cancer
por: Sturrock, M., et al.
Publicado: (2018)

Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database
por: Inada, Ayaka, et al.
Publicado: (2018)

Dentists’ Awareness of Medication-Related Osteonecrosis of the Jaw (Risk Factors, Drugs, and Prevention) in the Republic of Croatia
por: Bival, Sven, et al.
Publicado: (2023)

Osteonecrosis of jaw associated with bisphosphonate use
por: Rastogi, Ashu, et al.
Publicado: (2012)

Bisphosphonate-related osteonecrosis of the jaws (Bronj)
por: Beninati, Francesco, et al.
Publicado: (2013)

Osteonecrosis of the jaws in patients treated with bisphosphonates
por: Ata-Ali, Fadi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9t85vm2g71vmrcoq6vtm526pai